RETATRUTIDE: A COMPARATIVE LOOK

The increasingly popular class of GLP-1 receptor and GIP co-agonist medications, including tirzepatide, semaglutide, and the relatively introduced retatrutide, represent promising improvements in diabetes control. While all three operate by modulating sugar readings , they vary in their specific